GlassScriptPhysician profile
Ravy S Lu
NPI 1770539314
$5,431.00
in general payments reported to CMS, 2019-2025
36 companies · $1,300 in 2025
The $1,300 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $696 · 2020: $166 · 2021: $479 · 2022: $1,107 · 2023: $995 · 2024: $688 · 2025: $1,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,930 · Education: $53.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,929.73 |
| Education | $53.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $910.82 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $904.78 | 2021-2025 | |
| Exeltis, USA INC. | $478.14 | 2019-2025 | Slynd, Twirla |
| Astellas Pharma US INC | $448.98 | 2021-2025 | Veozah |
| Amgen INC. | $441.93 | 2019-2025 | Evenity, Prolia, Prolia |
| Sumitomo Pharma America, INC. | $381.66 | 2023-2025 | Myfembree, Gemtesa |
| Evofem Biosciences, INC. | $178.34 | 2020-2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $173.64 | 2019-2023 | |
| Allergan, INC. | $160.07 | 2019-2020 | |
| Myovant Sciences INC. | $119.22 | 2022 | |
| Daiichi Sankyo INC. | $111.89 | 2022-2025 | Injectafer |
| Millicent US INC | $110.43 | 2019-2025 | Intrarosa, Femlyv, Femring |
| Sage Therapeutics, LLC | $104.56 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $90.51 | 2019-2022 | |
| Organon LLC | $76.69 | 2023 | Nexplanon |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $69.94 | 2024 | |
| Vertical Pharmaceuticals, LLC | $61.66 | 2019 | |
| Coopersurgical, INC. | $60.85 | 2019-2023 | Paragard T 380a |
| Hologic Sales and Service, LLC | $56.48 | 2023-2025 | Aptima, Third Wave, Thinprep 2000 Processor |
| Mylan Pharmaceuticals INC. | $55.45 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $48.27 | 2025 | Qelbree |
| Amag Pharmaceuticals, INC. | $41.08 | 2019 | |
| Kci USA, INC. | $36.40 | 2019 | |
| Axonics, INC. | $35.15 | 2021-2022 | |
| Coloplast Corp | $34.66 | 2019 | |
| Mimedx Group, INC. | $29.07 | 2025 | |
| Channel Medsystems, INC. | $25.99 | 2023 | |
| Caldera Medical, INC | $25.60 | 2023 | Desara |
| Aspira Women'S Health INC | $24.06 | 2023 | Ova1 |
| Provepharm INC. | $23.96 | 2025 | Bludigo |
| Agile Therapeutics, INC. | $21.49 | 2021 | |
| Smith+Nephew, INC. | $21.01 | 2024 | Pico |
| Scynexis, INC. | $19.50 | 2022 | |
| Qiagen, LLC | $19.16 | 2023 | |
| Merck Sharp & Dohme LLC | $16.19 | 2023 | Gardasil 9 |
| Avion Pharmaceuticals | $13.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravy Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.